OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2025-12-31-accounts

Trustees’ Annual Report for the period

From 01.01.25 To 31.12.25

Charity name: HEALTH SECURITY, INNOVATION AND SYSTEM REFORM

Charity registration number: 1136879

Objectives and Activities

SORP reference
Summary of the purposes of
the charity as set out in its
governing document
Para 1.17 Health Security, Innovation and System
Reform’s main activity is to promote
evidence-based research, services and
efforts for the public benefit in all
health-related areas.
The purpose outlined above is achieved
through collaboratives, communication,
education and Health Research &
Scholarships.
Summary of the main
activities in relation to those
purposes for the public
benefit, in particular, the
activities, projects or
services identified in the
accounts.
Para 1.17 and
1.19
Main activities include supporting and
informing global collaborations
involving distinguished decision-
makers and influencers from across the
World.
Consider practical, lasting and
innovative solutions and efforts that
focus on global healthcare challenges.
Support and commission work
programmes which seek to address and
help raise the profile of global health
and security issues.
Statement confirming
whether the trustees have
had regard to the guidance
issued by the Charity
Commission on public
benefit
Para 1.18 Yes

Additional information (optional)

You may choose to include further statements where relevant about:

SORP reference Policy on grant making Para 1.38 Policy on social investment Para 1.38 including program related investment Contribution made by Para 1.38 volunteers Other

Achievements and Performance

SORP reference
Summary of the main
achievements of the charity,
identifying the difference the
charity’s work has made to
the circumstances of its
beneficiaries and any wider
benefits to society as a
whole.
Para 1.20 Who We Are
Through a variety of methods, we provide
access to a global healthcare community
dedicated to capturing and disseminating
the best evidence-based ideas and
practices.
Our vision
A healthier world through global
collaboration, innovation and shaping to
evidence-based policy.
Our mission
• We forge connections and help build
action-driven communities of knowledge
who work together to address today's most
pressing global healthcare challenges.
• We convene and collaborate with the
world's leading experts and the highest
levels of decision-makers.
• We create and disseminate world-class,
evidence-based content and knowledge.
• We promote active learning and support
within and between communities.
• We aim to influence healthcare policy
globally and improve health outcomes.
Activity
Health Security
Tackling Antimicrobial Resistance
(AMR): The Fleming Initiative
Building on the work undertaken in 2024,
we continued to support the development of
the Fleming Initiative, an ambitious
programme focused on addressing the
global challenge of antimicrobial resistance
(AMR).
Working alongside our partners at Imperial
College London and Imperial College
Healthcare NHS Trust, we supported efforts
to shape, develop and establish this
innovative initiative.
Tackling AMR requires not only scientific
and medical advances, but also greater
public awareness, collective action and
sustained behavioural change. Building on
the UK’s historic legacy of Alexander
Fleming’s discovery of penicillin in 1928, Fleming’s discovery of penicillin in 1928,
the Fleming Initiative aims to put society at
the heart of the response, bringing together
science, healthcare, industry, philanthropy
and the public to help address this critical
global challenge.
Our activity during the year focused on:
• Fundraising strategy and
support:Developing and
implementing a targeted programme
of activity to support fundraising,
drawing on the expertise of
specialist advisers and sector
experts.
• Case for support and
communications:Developing
publications, detailed dossiers and
supporting materials to articulate the
initiative’s vision, strengthen
fundraising efforts and raise wider
awareness.
• Partnership development:
Identifying and engaging potential
partners, supporters and funders to
build momentum behind the
initiative and support its long-term
ambitions.
• Expert engagement:Working with
specialists in philanthropy, industry
and the health sector to inform the
initiative’s development and support
its strategic direction.
• International collaboration:
Developing international
partnerships to lay the foundations
for a coordinated global effort
against AMR.
• Profile-raising and stakeholder
engagement:Supporting events
and engagement opportunities to
raise the profile of the initiative,
strengthen relationships with key
stakeholders and build support
across the scientific, healthcare,
philanthropic and business
communities.
Key outputs and progress included:
• Publications and thought
leadership:Development of
publications and supporting content
to communicate the scale of the
AMR challenge, articulate the
Fleming Initiative’s ambitions and
engage potential supporters.
• Fundraising progress:Supporting
fundraising activity through the
development of compelling
propositions, the identification of
prospective funders and
engagement with philanthropic and

other potential funding partners. [Specific fundraising successes and amounts can be included here.] • Profile-raising events: Supporting events and stakeholder engagement activities designed to increase the initiative’s visibility, communicate its purpose and build relationships with influential supporters and partners. [Key events and outcomes can be highlighted here.] • Strategic partnerships: Progressing relationships with organisations and individuals whose expertise, influence and resources can contribute to the initiative’s development. • Programme development: Advancing the strategic foundations, supporting materials and partnership network required to establish the initiative as a credible and influential global effort. The Fleming Initiative is intended to become a global endeavour, with its inaugural centre in London, where Fleming discovered penicillin in 1928. Its ambition is to build an international network of collaboration, combining scientific innovation with public engagement to drive meaningful and lasting progress against AMR. In July 2023, His Royal Highness The Prince of Wales became Patron of the Fleming Initiative, providing an important platform for its ambition to raise awareness and galvanise action on this global health challenge.

Additional information (optional) You may choose to include further statements where relevant about:

Achievements against Para 1.41 objectives set Performance of fundraising Para 1.41 activities against objectives set Investment performance Para 1.41 against objectives Other

Financial Review

Review of the charity’s
financial position at the end
of the period
Para 1.21 The charity currently has funds of
£2.2m.
Statement explaining the
policy for holding reserves
stating why they are held
Para 1.22 Our reserve policy is based on ensuring
the financial security of the charity. The
policy is to retain a reserve of
approximately 80%.
Amount of reserves held Para 1.22 £2.2m
Reasons for holding zero
reserves
Para 1.22 N/A
Details of fund materially in
deficit
Para 1.24 N/A
Explanation of any
uncertainties about the
charity continuing as a going
concern
Para 1.23 N/A

Additional information (optional)

You may choose to include further statements where relevant about:

The charity’s principal
sources of funds (including
any fundraising)
Para 1.47
Investment policy and
objectives including any
social investment policy
adopted
Para 1.46 The charity has an ethical investment
policy whereby we do not invest in
alcohol, tobacco, pornography and
military focused companies. Our
investment is managed through an SRI
fund from Newton Investment.
A description of the principal
risks facing the charity
Para 1.46
Other

Structure, Governance and Management

Description of charity’s
trusts:
Type of governing document
(trust deed, royal charter)
Para 1.25 TRUST DEED
How is the charity
constituted?
(e.g unincorporated
association, CIO)
Para 1.25 Trust, unincorporated
Trustee selection methods
including details of any
constitutional provisions e.g.
election to post or name of
any person or body entitled
to appoint one or more
trustees
Para 1.25 By appointment

Additional information (optional)

You may choose to include further statements where relevant about:

Policies and procedures
adopted for the induction
and training of trustees
Para 1.51
The charity’s organisational
structure and any wider
network with which the
charity works
Para 1.51
Relationship with any related
parties
Para 1.51
Other

Reference and Administrative details

Charity name HEALTH SECURITY, INNOVATION AND SYSTEM
REFORM
Other name the charity uses HSISR, HISR
Registered charitynumber 1136879
Charity’s principal address 45 Melton Court
Onslow Crescent
LONDON
SW7 3JH

Names of the charity trustees who manage the charity

1
2
3
4
5
6
7
8
Trustee name Office (if any) Dates acted if not
for wholeyear
Name of person (or body) entitled to
appoint trustee(if any)
Professor the Lord
Darzi of Denham
Mr. Gianluca
Fontana

– Corporate trustees names of the directors at the date the report was approved

Director name None

Name of trustees holding title to property belonging to the charity

Trustee name Dates acted if not for whole year None Funds held as custodian trustees on behalf of others Description of the assets held in this capacity N/A Name and objects of the charity on whose behalf the assets are held and how this N/A falls within the custodian charity’s objects Details of arrangements for safe custody and segregation of such assets N/A from the charity’s own assets

Funds held as custodian trustees on behalf of others

Additional information (optional)

Names and addresses of advisers (Optional information)

Type of Name Address
adviser

Name of chief executive or names of senior staff members (Optional information)

Exemptions from disclosure

Reason for non-disclosure of key personnel details

N/A

Other optional information

Declarations

The trustees declare that they have approved the trustees’ report above.

Signed on behalf of the charity’s trustees

Signature(s) Full name(s) Position (eg Secretary, Chair, etc) Date

HEALTH SECURITY INNOVATION AND SYSTEM REFORM (Charity Number 1136879) Accounts for the year ended 31 December 2025

Contents: Page 1 Balance Sheet Page 2 Statement of Financial Activities

HEALTH SECURITY INNOVATION AND SYSTEM REFORM (Charity Number 1136879) Accounts for the year ended 31 December 2025

Balance Sheet as at 31 December 2025

2025 2024
GENERAL FUNDS 2,216,962 2,028,800
FIXED ASSETS
Investments 2,078,171 1,954,947
CURRENT ASSETS
Cash at Bank 138,791 73,853
2,216,962 2,028,800

In my opinion, the above Balance Sheet and the accompanying statement of financial activities are in accordance with the clients books and records supplied to me.

Signed_______

Date_________

HEALTH SECURITY INNOVATION AND SYSTEM REFORM (Charity Number 1136879) Accounts for the year ended 31 December 2025

Statement of Financial Activities for the year ended 31 December 2025

2025 2024
INCOMING RESOURCES
Investment Income 49,129 43,609
RESOURCES EXPENDED
Grants awarded 36,000 4,509
Governance Costs 2 60
Net Resources 13,127 39,040
Investment Gains/(Losses) 174,094 96,609
Funds b/fwd 2,028,800 1,893,151
Adjustment fee handling 941
Funds c/fwd 2,216,962 2,028,800